Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • 3D Bioprinting Market Owing To Growth Within Biotechnology Sector from 2019 to 2028

    Jul 5, 2022, 09:37 AM by
    The global 3D bioprinting market is segmented based on technology, material, application and geography. Based on technology, the market is categorized into magnetic 3D bioprinting, laser-assisted bioprinting, inkjet 3D bioprinting and microextrusion 3D bioprinting.
    Full story
  • BOC Sciences Highlighted Carbohydrates Harvest Admiring Fans at CPhI North America 2022

    Jul 5, 2022, 09:36 AM by
    Full story
  • BOC Sciences Grandly Promotes: One-Stop CDMO Service Platform for Drug Development 

    Jul 5, 2022, 09:35 AM by
    Full story
  • BOC Sciences Fermentation CDMO Services Prompt a New Era for Pharmaceutical Compound Production

    Jul 5, 2022, 09:35 AM by
    Full story
  • BOC Sciences Contributes to a Large Portion of PseudoUridine Production for mRNA Vaccine R&D

    Jul 5, 2022, 09:35 AM by
    Full story
  • BOC Sciences Commitment at BIO 2022: From Concept to GMP Production

    Jul 5, 2022, 09:34 AM by
    Full story
  • IgGenix Demonstrates Potential for Single-Cell RNA-Sequencing in Tree Nut Allergies

    Jul 5, 2022, 09:33 AM by
    Full story
  • Millimeter-Sized Feats Of Engineering Could Enable Smart Drug Delivery

    Jul 5, 2022, 01:00 AM by User Not Found
    Bio-IT World | At Stanford University, precisely targeted drug delivery is in view using wireless micromachines that can navigate the rugged terrain of the human body, including the slippery surface of organs and vessels where blood flow may be impeded by hypertension and arterial plaques. The all-in-one amphibious robots’ locomotion is controlled by the strength and orientation of a three-dimensional magnetic field.
    Full story
  • CD ComputaBio Boosts Your Disease Research with Computational Proteomics Service

    Jul 1, 2022, 09:13 AM by
    Full story
  • Innovative Impurity Isolation and Identification Techniques at BOC Sciences to Address Pharmaceutical Impurity Issues

    Jul 1, 2022, 09:11 AM by
    BOC Sciences announced impurity isolation and identification services using traditional and innovative impurity techniques.
    Full story
  • NRG Therapeutics Selects Domainex to be its Integrated Drug Discovery Partner for its Biomedical Catalyst Funded Parkinson’s Disease Project

    Jun 30, 2022, 09:18 AM by
    Full story
  • MultiOmic Health and Mesh Bio partner to use AI to develop precision medicines and diagnostics for chronic metabolic disease

    Jun 30, 2022, 09:17 AM by
    MultiOmic Health, an artificial intelligence (AI)-enabled drug discovery company, and Mesh Bio, a digital health startup transforming chronic disease management through predictive analytics, today announce their partnership to conduct an observational clinical study on patients with chronic metabolic disease and increased risk of complications such as chronic kidney disease. The partnership will provide access to data from patient populations in Asia that have historically been underrepresented in chronic metabolic disease studies.
    Full story
  • Introducing Inizio: Ashfield and Huntsworth unite expertise to form powerful strategic partner for health and life sciences companies

    Jun 30, 2022, 09:17 AM by
    Full story
  • Saama Technologies Announces Appointment of New CEO Vivek Sharma

    Jun 30, 2022, 09:17 AM by
    #1 AI clinical analytics platform company Saama Technologies welcomes global life sciences industry expert Vivek Sharma as new CEO
    Full story
  • Kyruus Announces Paul Merrild as Company’s First President

    Jun 30, 2022, 09:15 AM by
    Leadership Team Expansion Follows Year of Accelerated Growth
    Full story
  • PHASTAR Names Chris Schoonmaker as Chief Operations Officer

    Jun 30, 2022, 09:14 AM by
    PHASTAR Names Chris Schoonmaker as Chief Operations Officer  London, UK and Durham, NC - June 29, 2022 – PHASTAR, a global specialist biometrics contract research organization (CRO) offering industry leading data management, data science, statistical consulting, and clinical trial reporting services, today announces that Chris Schoonmaker has joined the company as Chief Operations Officer. Chris will direct PHASTAR’s operational strategy with a key focus on ensuring quality deliverables and providing a positive customer experience.
    Full story
  • Remote AI-Run Robotics Lab, Gut Microbiome as Targetable Biomarker, More

    Jun 30, 2022, 01:00 AM by User Not Found
    Bio-IT World | A comprehensive ligand- and structure-based design platform delivers new and improved features for molecule design; an advanced automated GC headspace sampler and GC/mass spectrometry solution helps lab teams simplify operations; 10x Genomics releases a series of profiling products; and more.
    Full story
  • Alzheimer’s Disease Diagnostic Market – Global Industry Size, Trends and COVID-19 Impact Analysis (2022 to 2028)

    Jun 29, 2022, 09:18 AM by
    Full story
  • Sharp Adds New Talent in Global Operations and Finance to Senior Leadership Team

    Jun 29, 2022, 09:16 AM by
    Full story
  • Citeline and Norstella Unite to Offer Life Sciences Clients a Full Suite of Commercial and Clinical Solutions

    Jun 29, 2022, 09:15 AM by
    Citeline and Norstella Unite to create a new organization that will help life sciences companies improve strategic decision-making and accelerate the mission of smoothing access to therapy from pipeline to patient
    Full story
  • «
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129 (current)
  • 130
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy